Professor Gal Markel
Oncologist. An international expert in immuno-oncology, medical oncology and innovative treatment of skin cancer. Professor of oncology and immunology.
Professor Gal Markel is one of the best-known oncologists in Israel and a world-class specialist in the treatment of melanoma, non-melanoma skin tumors and the use of modern immuno-oncology therapies.
Professor Markel is a highly qualified oncologist with deep expertise in clinical and immune oncology, chemotherapy, targeted therapy and personalized cancer treatment. He is an international expert in translational molecular biology and clinical immuno-oncology.
In his practice he takes a comprehensive approach, combining standard clinical protocols with innovative scientific developments and individual treatment regimens.
Over the years the professor has helped thousands of patients with various forms of cancer, including aggressive and metastatic tumors.
- Faculty of Medicine, Hebrew University (Jerusalem)
- Internship and residency in oncology: Hadassah Medical Center
- Doctoral studies in clinical immunology, Hebrew University
- Doctor of medical sciences (PhD), dissertation defended with distinction
- Master of medicine: 2001
- Professor of medicine: since 2007
Professor Gal Markel is an honorary member of leading world oncology societies:
- European Society for Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
- Israeli Society of Clinical Oncology and Radiotherapy
- American Association of Immunologists
- Alliance for Melanoma Research
- Israel Cancer Research Fund
- Australasian Association of Cancer Registries
For his contribution to the development of oncology the professor has repeatedly received government grants and scientific awards.
Professor Markel specializes in traditional and innovative treatment of cancer, including complex and rapidly progressing forms. In his practice he uses modern personalized treatment protocols based on molecular diagnostics and the principles of immuno-oncology.
Key areas of work:
- treatment of melanoma, including aggressive and metastatic forms
- treatment of non-melanoma skin tumors: basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma
- immuno-oncology therapy
- targeted therapy
- chemotherapy
- development of individual treatment protocols
The professor pays particular attention to the therapy of rapidly progressing melanoma, applying a comprehensive multidisciplinary approach and the latest international clinical guidelines.